Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform
NCT ID: NCT02475967
Last Updated: 2018-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2016-01-31
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention
NCT00315978
Bystander Helping Behaviour for Myocardial Infarction Following First Aid Training
NCT00954161
Usability and Feasibility of the NutriQuest Application
NCT05884489
Format of Patient Education for Different Sociodemographic Groups
NCT02961517
Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making
NCT04437069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence.
E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.
Intervention group
The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.
Control group
The control group patients receive conventional cardiac care alone.
Control group
The control group patients receive conventional cardiac care alone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention group
The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.
Control group
The control group patients receive conventional cardiac care alone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages
* Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages
* Patients participating in another trial during the Pilot study period
* Patients refusing to provide signed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jessa Hospital
OTHER
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
prof. dr. Paul Dendale
prof. dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ines Frederix, drs.
Role: STUDY_CHAIR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ZOL
Genk, , Belgium
Jessa Ziekenhuis
Hasselt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDEN-IFRE 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.